Professionals and executives of biopharma and medical device companies are invited to attend DGE’s 3rd Clinical Trial Agreement Forum, a virtual online livestream event, on September 29-30, 2022. The conference will discuss how the evolution of the virtual clinical trial landscape requires flexibility when designing and modifying clinical trial agreements (“CTAs”). Clinical trials have seen many changes with the advent of virtual clinical trials, where telemedicine and remote monitoring are used. Changes that impact the CTAs include incorporating cybersecurity language, more complicated indemnification, complexities of third-party contracting, and an increase in remote monitoring.
The conference will provide insights into novel industry practices and technological trends for successful results as well as speeding up contracting and study start-ups. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.
This DGE forum offers a phenomenal backdrop for discussing and learning important trends, strategies, and challenges faced in negotiating CTAs. Attendees can connect and communicate with industry stalwarts, gaining valuable insights into the latest industry trends regarding patient data and samples through discussions, panels, and more.
Featured topics and discussions at the conference:
- Understand the biggest hurdles in negotiating CTAs from sites and sponsors
- Clearly understand the importance and implications of informed consent and future use of patient data and samples
- Embody cybersecurity language in CTAs and remote monitoring agreements
- Define the patient injury provision in subcontracts and clinical trial agreements
- Learn strategies to manage negotiation budgetary restraints and timelines efficiently
- Understand how to protect IP and reduce risks in indemnification and subject injury
The event starts with the chairperson’s address, to be followed by discussions from eminent industry heads respected for their wide knowledge and experience in their respective fields. It’s critical to fully understand the best practices and associated strategies for success in this ever-changing landscape.
The event is conducted in a virtual environment where biotech, pharma, and medical device company experts from all over the world can be a part of the event. Understand how better integration between research and clinical care can lead to novel and much more effective contracting strategies.
To learn more, please visit https://ibn.fm/yoWrN
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment